Imdevimab (anti-Spike RBD) - Primärer Antikörper, specific to Spike RBD, >95% (SDS-PAGE&SEC), Human IgG1, INHIBITOR of Spike glycoprotein inhibitor, INHIBITOR of Spike glycoprotein inhibitor

CAS: 2415933-40-1 Cat. No.: Ab182897

GRADE & PURITY Animal Free, Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC-HPLC), See COA

Application

Animal Model, ELISA, Flow Cytometry, Functional Assay

Host species

Mensch

Reactive species

Schweres akutes respiratorisches Syndrom Coronavirus 2

Isotype

Human IgG1

Conjugation

Unconjugated

Übersicht

Imdevimab (anti-Spike RBD) is a human monoclonal antibody to target SARS-CoV-2 virus, which causes COVID-19. Imdevimab (anti-Spike RBD) lacks efficacy against COVID-19 variants. Imdevimab (anti-Spike RBD) can be used in combination with Casirivimab, it reduces viral load and improves diseases.

Purity

>95% (SDS-PAGE&SEC)

Endotoxin Level

< 1.0EU/mg

Specifications

Product Name

Imdevimab (anti-Spike RBD) - Primärer Antikörper, specific to Spike RBD, >95% (SDS-PAGE&SEC), Human IgG1, INHIBITOR of Spike glycoprotein inhibitor

Synonyme

Spike RBD antibody | Anti-Spike RBD antibody | Anti-Human Spike RBD Recombinant Antibody | Anti-Spike RBD Reference Antibody | SARS-CoV-2 antibody | Anti-SARS-CoV-2 antibody | REGN10987

Spezifikationen & Reinheit

Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA

Wirtsspezies

Mensch

Spezifität

Spike RBD

Konjugation

Unconjugated

Note

Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated

Aktionsart

INHIBITOR

Mechanismus der Wirkung

INHIBITOR of Spike glycoprotein inhibitor

Isotyp

Human IgG1

Lichterketten-Typ

lambda

SDS-PAGE

144.14 kDa

Verfahren zur Reinigung

Protein A purified

Reinheit

>95% (SDS-PAGE&SEC)

Konzentration

See COA

CAS

2415933-40-1

Product Line

Biologische Produkte

Lagerung und Versand

Form

Liquid

Storage

Store at -80°C,Avoid repeated freezing and thawing

Verschickt in

Dry ice packs + Cold packs

Stabilität und Lagerung

Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.

Bilder

ELISA: Imdevimab (anti-Spike RBD) (Ab182897)

Imdevimab (anti-Spike RBD) (Ab182897) - ELISA
Immobilized Human Spike RBD protein (rp155929) at 1.0 μg/mL can bind Imdevimab (anti-Spike RBD) (Ab182897) with the EC50 of 7.82 ng/mL.

SEC: Imdevimab (anti-Spike RBD) (Ab182897)

Imdevimab (anti-Spike RBD) (Ab182897) - SEC
The purity of Imdevimab (anti-Spike RBD) (Ab182897) is more than 95% verified by HPLC.

Häufig gestellte Fragen

What does Animal Free mean?

Animal Free indicates that the material has been processed and tested for specialty industrial processing. Specifications focus on the impurities that affect performance in that application — for example, metal content for electronics, particle size for batteries, refractive index for optics, or moisture content for moisture-sensitive processes.

How should this product be stored?

Store at ?80 °C. Avoid repeated freeze–thaw cycles. Aliquot into single-use volumes before freezing.

What does Carrier Free mean?

Carrier Free indicates that the material has been processed and tested for specialty industrial processing. Specifications focus on the impurities that affect performance in that application — for example, metal content for electronics, particle size for batteries, refractive index for optics, or moisture content for moisture-sensitive processes.

How is this product shipped?

This product ships frozen with dry ice and cold packs. Unpack on arrival and transfer it to the storage condition stated above; handle dry ice with insulated gloves in a ventilated area.

What are the CAS number, molecular formula and molecular weight?

The CAS Number is 2415933-40-1.

What documentation is provided?

Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Which species reactivity has this antibody been validated against?

Validated reactivity is listed on the PDP and on each lot's datasheet. We validate against the most commonly tested species for the target (Imdevimab (anti-Spike RBD)); cross-reactivity in untested species may exist but is not guaranteed. Contact technical support for specific species inquiries.